The Miller Lab and the Center for Merkel Cell Carcinoma at Mass General Cancer Center is actively pursuing several lines of investigation into Merkel cell carcinoma, a rare, aggressive type of skin cancer. Dr. Miller and his team are developing a clinical and translational research program that incorporates basic science to better understand the fundamental biology of MCC, translational research to investigate biomarkers that may predict response to therapy, and clinical trials to improve the therapeutic options for patients with the disease.
Benefiting Mass General Cancer Center
$165
raised out of
$100
goal
Benefiting Mass General Cancer Center
$165
raised out of
$100
goal
Donors
$25.00 from Ken Hutton
$15.00 from Jen Kallin
"Good luck, Lacey! Great cause."
$50.00 from Michael Lepore
"Good luck! Thanks for helping a great cause!"
$50.00 from Peter Bakkala
"Go Lacey! ⚡️⚡️⚡️
I’ll be behind you all the way.
Way behind, actually. See you there!"